Senti Biosciences Inc.

NASDAQ: SNTI · Real-Time Price · USD
1.55
0.02 (1.31%)
At close: Aug 15, 2025, 3:59 PM
1.50
-3.19%
After-hours: Aug 15, 2025, 07:51 PM EDT

Senti Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-58.32M -54.79M -52.79M -70.87M -56.95M -64.44M -71.05M -70.58M -72.28M -65.14M -58.22M -50.9M -45.67M -34.32M -43.52M -33.69M -22.28M -22.08M
Depreciation & Amortization
5.33M 5.32M 5.85M 5.87M 6.22M 5.96M 5.43M 4.9M 4.12M 3.84M 3.92M 4.01M 3.85M 3.48M 3.01M 2.51M 1.63M 1.07M
Stock-Based Compensation
4M 1.7M 1.75M 3.21M 2.96M 7.17M 9.67M 11.82M 13.7M 19.49M 16.39M 12.91M 11.25M 2.58M 2.29M 1.62M 996K 434K
Other Working Capital
-3.69M -1.32M -1.66M 4.63M 7.37M 4.14M 2.72M 3.35M 2.04M 7.88M 9.81M 4.64M 5.67M -662.49K -839.49K -439.49K -727.49K n/a
Other Non-Cash Items
9.39M 7.61M 9.02M 27.81M 703K 798K -1.27M -7.61M -1.53M -11.56M -10.89M -5.5M -6.25M 3.9M 15.99M 5.23M 5.69M 5.7M
Deferred Income Tax
n/a n/a n/a -3.17M 545K 165K 165K 3.33M -380K n/a n/a -4.34M -3.87M -3.87M -3.87M 469.71K n/a n/a
Change in Working Capital
-7.91M -4.14M -1.46M 5.98M 7.85M 6.35M 4.67M 3.78M 7.25M 12.22M 13.9M 5.96M 4.17M -2.42M -2.42M 370.51K -723.49K 4K
Operating Cash Flow
-48.49M -43.77M -41.4M -34.93M -42.44M -47.77M -52.4M -54.36M -49.12M -41.14M -34.9M -37.86M -36.53M -31.77M -30.08M -25.05M -16.25M -15.31M
Capital Expenditures
-207K -11K -26K -19K -1.88M -5.55M -12.04M -20.57M -32.91M -40.5M -41.37M -36.83M -23.56M -12.72M -5.54M -2.38M -1.45M -1.03M
Cash Acquisitions
12K n/a n/a 105K 105K 105K 3.1M 2.99M 2.99M 2.99M n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a 17.99M 17.99M 17.99M n/a -58.58M -58.58M -58.58M -40.59M -230M n/a -230M -230M n/a -230M n/a
Sales Maturities Of Investments
n/a n/a n/a -60M -37M -15M n/a 60M 37M 15M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
60K 60K 60K 3.05M 25.99M 47.99M 45M 1.43M -21.57M -43.58M -40.59M 230M n/a -230M -230M -460M -230M n/a
Investing Cash Flow
-135K 49K 34K 146K 21.23M 39.56M 30.08M -19.14M -54.48M -84.08M -81.96M -36.83M -23.56M -242.3M -235.12M -231.96M -231.03M -1.03M
Debt Repayment
n/a n/a n/a 2.32M -108K -135K -135K -27K -27K 5.17M 5.17M 5.17M 5.17M n/a n/a n/a n/a n/a
Common Stock Repurchased
10K 10K 10K -12.06B -12.06B 512K 512K 12.06B 12.06B 196K 196K n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -23.16K -27.06K -30.98K -31.95K -8.78K -4.89K -965 n/a
Other Financial Acitivies
4.27M 4.27M 4.68M 674K 641K 949K 914K 1.13M 664K 113.8M 113.38M 112.47M 113.45M -160.5M -156.49M -126.43M -126.92M 33.59M
Financial Cash Flow
54.33M 53.32M 53.73M 3M 533K 814K 779K 1.1M 637K 118.97M 118.55M 117.7M 118.67M 232.09M 236.1M 266.11M 265.62M 33.59M
Net Cash Flow
5.72M 9.6M 11.86M -29.42M -18.31M -5.03M -18.66M -72.41M -102.97M -6.25M 1.7M 43.01M 58.58M -68M -55.12M -16.93M -7.68M 17.25M
Free Cash Flow
-48.7M -43.78M -41.42M -34.95M -44.32M -53.32M -64.43M -74.93M -82.03M -81.64M -76.27M -74.69M -60.09M -44.49M -35.62M -27.43M -17.7M -16.34M